/Companies

Portola Pharmaceuticals

acquired by Alexion

6 known investors

Find your way into Portola Pharmaceuticals

Sign up to see every warm intro you have to Portola Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Portola Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Portola develops research and investigates new targets, modalities, and technologies to address rare disease challenges for patients and their families.

Investors · 6

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

4 people who came through Portola Pharmaceuticals went on to found or lead other companies.

Frequently asked questions

What does Portola Pharmaceuticals do?
Portola develops research and investigates new targets, modalities, and technologies to address rare disease challenges for patients and their families.
Who are Portola Pharmaceuticals's investors?
Portola Pharmaceuticals's investors include Bluebird Ventures, Frazier Life Sciences, Lightstone Ventures, Prospect Venture Partners, Khosla Ventures, NFDG.
Who acquired Portola Pharmaceuticals?
Portola Pharmaceuticals was acquired by Alexion.